2 results
Approved WMOCompleted
1. To assess the safety, tolerability, and efficacy of ABBV-3373 administered every other week (eow) intravenously (IV) in subjects with moderately to severely active RA on background MTX.2. To compare clinical efficacy of ABBV-3373 with adalimumab…
Approved WMOCompleted
In this RCT with the duration of 6 months we will examine the longterm (cost) effectiveness of increasing protein intake to 1.2 g/kg body weight/d on physical functioning in community-dwelling older adults with a habitual protein intake < 1.0…